Pharmacogenetics of asthma

Chest

Volumn 130, Issue 6, 2006, Pages 1873-1878

  Hall, Ian P ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Asthma; Pharmacogenetics; 2 agonists

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID RECEPTOR; HISTAMINE H1 RECEPTOR; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; PHOSPHODIESTERASE IV; SALBUTAMOL; SALMETEROL; STEROID; THEOPHYLLINE;

3' UNTRANSLATED REGION; ARTICLE; ASTHMA; CLINICAL TRIAL; DRUG CHOICE; DRUG RECEPTOR BINDING; DRUG RESPONSE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; OSTEOPOROSIS; PHARMACOGENETICS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33845932502     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.6.1873     Document Type: Article

References (21)

1. Fenech A, Hall IP. Pharmacogeneties of asthma. Br J Clin Pharmacol 2002; 53:3-15
2. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8:334-339
3. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 1993; 268:23116-23121
4. Green SA, Rathz DA, Schuster AJ, et al. The Ile164 β(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s). Eur J Pharmacol 2001; 421:141-147
5. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33:9414-9419
6. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000; 97:10483-10488
7. Israel E, Drazen JM, Liggett SB, et al. The effect of polymorphisms of the β(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000; 162:75-80
8. Israel E, Chinchilli VM, Ford JG, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004; 364:1505-1512
9. Nelson HS, Weiss ST, Bleecker ER, et al. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129:15-26
10. 2- adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br J Clin Pharmacol 2004; 57:68-75
11. Wechsler ME, Lehman E, Lazarus SC, et al. β-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 2006; 173:519-526
12. 2-adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol. Thorax 2004; 59:662
13. In KH, Asano K, Beier D, et al. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997; 99:1130-1137
14. Drazen JM, Yandava CN, Dube L, et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 1999; 22:168-170
15. Fowler SJ, Hall IP, Wilson AM, et al. 5-Lipoxygenase polymorphism and in vivo response to leukotriene receptor antagonists. Eur J Clin Pharmacol 2002; 58:187-190
16. 4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma. Pharmacogenetics 2002; 12:565-570
17. 4 synthase polymorphisms and responsiveness to leukotriene antagonists in asthma. Br J Clin Pharmacol 2003; 56:422-426
18. Lima JJ, Zhang S, Grant A, et al. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 2006; 173:379-385
19. Hakonarson H, Thorvaldsson S, Helgadottir A, et al. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. JAMA 2005; 293:2245-2256
20. Hakonarson H, Bjornsdottir US, Halapi E, et al. Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. Proc Natl Acad Sci USA 2005; 102:14789-794
21. Tantisira KG, Lake S, Silverman ES, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled coiticosteroids. Hum Mol Genet 2004; 13:1353-1359